Table 3 Fold reduction in biofilm formation of the tested compounds compared to the untreated control.
Chitosan-NPs | Salicylic-acid | M1 | M2 | M3 | M4 | |
|---|---|---|---|---|---|---|
Candida albicans | 4.95e ± 0.029 | 4.21e ± 0.091 | 8.31a ± 0.088 | 7.22b ± 0.042 | 5.38d ± 0.033 | 6.42c ± 0.067 |
Staphylococcus aureus | 3.39b ± 0.074 | 3.32b ± 0.054 | 3.42b ± 0.023 | 3.21b ± 0.076 | 4.69a ± 0.047 | 2.76c ± 0.032 |
Escherichia coli | 2.75c ± 0.083 | 2.97c ± 0.025 | 2.85c ± 0.011 | 3.9a ± 0.029 | 3.42b ± 0.067 | 3.79b ± 0.042 |
Klebsiella pneumoniae | 3.34d ± 0.036 | 3.22d ± 0.035 | 3.66c ± 0.089 | 4.54b ± 0.052 | 5.56a ± 0.028 | 4.95b ± 0.017 |